Tag Archives: health

What to Watch: Vaccines – Calling the Shots

vaccines-calling-shots-vi

Recently, PBS’s NOVA had an episode on the reemergence of diseases (including measles, whooping cough, and mumps) that had previously been largely eradicated in the US by vaccines, in part because nervous parents are skipping their children’s shots. At least ten percent of parents delay or skip some recommended vaccines, and one percent don’t vaccinate at all. What’s driving people away, and what are the consequences? Those are the questions explored in Vaccines — Calling Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

San Francisco Chronicle: High Drug Co-Pays Deny Needed Treatments

Jim Greenwood

Today, the San Francisco Chronicle published an op-ed that I wrote on the importance of ensuring access to treatments for debilitating diseases that are saving millions of patients from pain and possible death. Patients rightly expect their health insurance plan to cover the best medicines based on their unique needs, at an out-of-pocket cost that makes these therapies accessible. Insurance companies and their allies, seeking to deflect blame for increased premiums at a time of Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

CNN: Sandy’s Story

scientist-eyedropper

CNN launched a new series profiling Sandy Halperin, a dentist and Harvard assistant professor, to raise awareness for the devastating impact of Alzheimer’s disease on a patient and his family. Producer Stephanie Smith describes Sandy’s Story as ‘an unprecedented look at the cruel journey of a vibrant, once healthy man as he gradually loses his memory.’ Halperin was diagnosed with early stage Alzheimer’s disease at age 60. The in-depth package explores the day-to-day reality of Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Ebola Outbreak Highlights Value of Cures

shutterstock_26191726

Forbes recently published an op-ed comparing the outbreak and spread of the Ebola virus with the value of cures to prevent disease and save lives. The author – Merrill Matthews – is a resident scholar with the Institute for Policy Innovation in Dallas, Texas. Matthews asserts that drug companies are in the business of discovering cures for deadly and debilitating diseases, and need support for expediting research and development by cutting through red tape and Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

Patients Suffering from Gaucher’s Disease Deserve Better

scientist-eyedropper

Gaucher Disease is one of the over 6,000 rare diseases that affect patients worldwide, representing a frontier of unmet medical need [NCATS, NIH]. The challenges for drug development generally—long and costly research and development timelines—are exacerbated by the inherently small patient populations affected by rare diseases. These patients can be difficult to identify and geographically dispersed and their clinical presentation can be quite disparate, complicating the design and recruitment for clinical trials used to determine Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,